Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) is anticipated to announce its Q1 2025 earnings results after the market closes on Thursday, May 15th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $7.23 million for the quarter.

Sensus Healthcare Stock Performance

Shares of NASDAQ SRTS opened at $4.59 on Wednesday. Sensus Healthcare has a 52-week low of $4.01 and a 52-week high of $9.33. The stock has a market cap of $75.71 million, a P/E ratio of 11.48 and a beta of 1.30. The firm has a 50 day moving average price of $4.60 and a 200 day moving average price of $6.16.

Analyst Ratings Changes

Several research firms have weighed in on SRTS. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of Sensus Healthcare in a report on Friday, April 4th. Lake Street Capital dropped their price target on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating on the stock in a research report on Tuesday, March 11th.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.